Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex'

The primary objective of the study is to evaluate the efficacy of BIIB033 in participants
with active relapsing multiple sclerosis (MS) when used concurrently with Avonex.

Secondary objectives of this study in this study population are to assess the safety,
tolerability, and population pharmacokinetics of BIIB033 when used concurrently with Avonex.

本研究的主要目的为评估BIIB033联合Avonex治疗活动性复发型多发性硬化（MS）受试者的疗效。本研究针对该受试人群的次要目标为评估BIIB033联合Avonex使用时的安全性、耐受性及群体药代动力学。